Skip to main content
Show — Main navigation
Hide — Main navigation
Home
About
The Chair
Inquiry Team
Expert Groups
Inquiry Intermediaries
Core Participants
Legal Representatives
Financial Reports
Approach
Terms of reference
List of Issues
Statements of approach
Inquiry Principles
News
News
Newsletter Archive
Reports
Compensation Framework Study
First Interim Report
Second Interim Report
The Inquiry Report
Publication Day
Evidence
Evidence
Hearings Archive
Compensation
Support
Confidential Psychological Support
Interim Payments
Support Groups
Get in touch
Infected Blood Support Schemes
Treatment and aftercare
Medical Evidence
Expenses Guidance
Search
Accessibility Tool
Zoom in
Zoom out
Reset
Contrast
Accessibility tool
Listen
Get in touch
Quick Exit
Subscribe to Search results
Search
Sort your search results
Relevance
Title
Changed
Following Professor Gallo's HTLV-3 press conference, the US Secretary of State for Health predicted there would be a test to screen blood widely available within six months.
Published on:
25 July, 2024
Five pharmaceutical companies in the US were chosen to manufacture AIDS blood tests.
Published on:
25 July, 2024
Professor Weiss wrote an article on AIDS in Nature, which stated that there was no longer any doubt that AIDS was caused by an infectious agent and emphasised that ELISA screening tests for blood supplies were "urgently needed".
Published on:
25 July, 2024
Dr Gunson reported that a HTLV-3 test produced by Dr Tedder and Professor Weiss would be available within the foreseeable future and the Blood Transfusion Service had agreed at a meeting with Dr Tedder that it would start appraisal of their test as soon as possible. Dr Gunson also anticipated that a major decision to proceed to routine screening of all blood would be required.
Published on:
25 July, 2024
Professor Tedder stated that various UK HIV tests were available by mid July 1984. However, though these were in used in laboratories, there was little widespread knowledge of this at the time.
Published on:
25 July, 2024
Professor Tedder stated he aimed to produce a competitive test that was one step instead of two.
Published on:
25 July, 2024
Professor Tedder told the Inquiry that despite being advised differently, Porton Down decided to develop an antigen using an alternative and unsuccessful method.
Published on:
25 July, 2024
In a letter from Dr Fraser to Dr Smithies, it was stated that a screening test for AIDS would likely be available within the next 8 weeks and the implications of instituting a testing regime suggested there was an urgent need for a working party on AIDS.
Published on:
25 July, 2024
At a Scottish National Blood Transfusion Service meeting, directors proposed a UK-wide working group on AIDS and said that such a group should be encouraged to mount donor screening studies.
Published on:
25 July, 2024
In a letter to the Scottish Home and Health Department, Dr Cash conveyed the views of Scottish National Blood Transfusion Service directors that there should be a UK-wide working group on blood transfusion and AIDs.
Published on:
25 July, 2024
In an internal minute within the Department of Health and Social Security, Dr Smithies called for an invited group of experts to plan ahead to give guidance to health authorities about the consequences of being able to screen for AIDS. It was planned to start screening all blood donors at the North London RTC in October 1984.
Published on:
10 October, 2024
A paper was produced by the Department of Health and Social Security titled "Aids Immune Deficiency Syndrome [AIDS] - Current Developments". It highlighted that fewer than 20% of patients had survived more than 2 years after AIDS had been diagnosed, that the number suffering was expected to double within 6 months, and the importance of a screening test for the UK National Blood Transfusion Service.
Published on:
25 July, 2024
At the internal Department of Health and Social Security meeting, it was agreed that ministers should be made aware of the screening of all donors at the North West London RTC, proposed to start in October, the need for funding to scale up the production of the test reagent, and the further need to set up a working group.
Published on:
25 July, 2024
In a briefing note, Lord Glenarthur wrote that the UK HTLV-3 screening test developed by Dr Weiss and Dr Tedder was regarded as more sensitive, specific, and possibly more reliable than other tests available in the US.
Published on:
25 July, 2024
Abbott, Litton, DuPont, Travenol-Genetech Diagnostics and Electronuecelonics were selected by the US Public Health Service to develop tests for AIDS and were provided with Dr Gallo's cell line.
Published on:
25 July, 2024
A test for HTLV-3 antibodies produced by Abbott was licensed for use by the Food and Drug Administration in the US. National implementation was expected within 2-6 weeks.
Published on:
25 July, 2024
Very quickly after the Gallo tests became available, a number of European countries and Australia announced the start of universal screening of blood donations.
Published on:
25 July, 2024
Lord Glenarthur decided the cost of AIDS screening should be met from the existing budgets of regional health authorities. Lord Glenarthur was also briefed that there were numerous medical and ethical implications of such testing which were due to be examined by a working group on AIDS.
Published on:
25 July, 2024
Lord Glenarthur queried whether all blood was being screened for AIDS and asked when the UK would be able to do this.
Published on:
25 July, 2024
An article titled "Panic and the blood" was published in The Guardian, which argued that the UK's response to the AIDS crisis was too slow.
Published on:
25 July, 2024
Pagination
First page
First
Previous page
Previous
…
Page
2230
Page
2231
Page
2232
Page
2233
Current page
2234
Page
2235
Page
2236
Page
2237
Page
2238
…
Next page
Next
Last page
Last